Thymic Peptides and Antimicrobial Peptides

Thymosin alpha-1 is a 28-residue N-acetylated peptide derived from prothymosin alpha. Thymulin is a nonapeptide that requires zinc for its biological activity, so the zinc complex and the free peptide are distinct species. Thymalin is a peptide extract of thymus tissue rather than a single defined compound. Cell-culture studies of these peptides measure T-cell maturation markers and cytokine expression.

LL-37 is the 37-residue cationic, amphipathic peptide cleaved from the human cathelicidin precursor hCAP18. It is studied for membrane disruption in bacterial and model membranes, measured by minimum inhibitory concentration and membrane-permeabilisation assays. KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-MSH, a fragment of that hormone rather than a melanocortin receptor agonist, studied for NF-kB pathway signalling in cultured epithelial cells.

Identity is established by mass spectrometry: an intact mass, or a precursor and fragment transition (MRM) matched against a reference standard, confirms that the sequence in the vial is the one on the label. Purity is a chromatographic figure, the principal peak area by reversed-phase HPLC, and it bounds peptide-related impurities only; it says nothing about counterion, water or residual solvent content, which is why net peptide content is reported separately. Lyophilised material is stored cold, dry and dark, and a certificate states what was measured on one named lot. Cationic amphipathic peptides such as LL-37 adsorb to glass and plastic and can aggregate, which affects both the amount retrieved from a sample and the apparent purity; low-binding materials are used in handling. Tissue extracts such as thymalin cannot be given a single-compound purity and are described by composition instead.

Immunology readouts are sensitive to cell source, donor variation and endotoxin contamination of the test material, so a study should report endotoxin levels for the peptide used. Thymosin alpha-1 has a separate clinical literature in some jurisdictions, which reports organism outcomes and is outside the scope of a research-use reference.